Institution

AOU San Giovanni di Dio e Ruggi d'Aragona

Salerno, ItalyWebsite

Also known as: Azienda Ospedaliero Universitaria San Giovanni di Dio e Ruggi d'Aragona · Ospedale San Leonardo · Ospedali Riuniti San Giovanni di Dio e Ruggi d'Aragona · AOU

8running trials
5closed trials
1researcher
3,414publications (OpenAlex)

Researchers

Maria Teresa Pellecchia

Running trials

Active, not recruiting
Advanced Robotic Beds for the Early Rehabilitation of Cardiac Surgery Patients
NCT07273669· University of Salerno· Source
Recruiting
Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
NCT06965374· AbbVie· Source
Recruiting
Master Framework For Relapse or Refractory Acute Myeloid Leukemia
NCT06459024· Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS· Source
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source
Active, not recruiting
Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT05696717· Phase 3· Theravance Biopharma· Source
Active, not recruiting
LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
NCT04999423· Microvention-Terumo, Inc.· Source
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source
Active, not recruiting
Inspiris Resilia Durability Registry
NCT03666741· Institut für Pharmakologie und Präventive Medizin· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Acute myeloid leukaemia1 recruiting
Childhood cancers1 recruiting
Chronic lymphocytic leukaemia1 recruiting
Parkinson disease1 recruiting

Closed trials

Completed
A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy
NCT06058741· AbbVie· Source
Completed
Study of ATH434 in Participants with Multiple System Atrophy
NCT05109091· Phase 2· Alterity Therapeutics· Source
Terminated
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
NCT04551066· Phase 3· Incyte Corporation· Source
Completed
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
NCT04589728· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source
Completed
Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
NCT03367299· Phase 2· Gruppo Italiano Malattie EMatologiche dell'Adulto· Source

Registry name variants (10)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

AOU "San Giovanni di Dio e Ruggi d'Aragona"
Salerno, 84135
5 trials
Aou "San Giovanni Di Dio E Ruggi D'Aragona" - Salerno - Uoc Ematologia E Trapianti Di Cellule Staminali Emopoietiche
Salerno
2 trials
- NCT04867915Study on the Diagnosis and Management of CLL in Italy by GIMEMA
  Contact: Carmine Selleri
- NCT04589728Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno
Salerno, 84131
1 trial
- NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
AOU San Giovanni di Dio Ruggi d'Aragona
Salerno
1 trial
- NCT05109091Study of ATH434 in Participants with Multiple System Atrophy
AOU San Giovanni di Dio Ruggi d'Aragona - Scuola Medica Salernitana /ID# 259456
Salerno, 84131
1 trial
- NCT06058741A Study to Asses Effectiveness and Treatment Management of Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in Adult Participants Ineligible for Intensive Chemotherapy With de Novo Acute Myeloid Leukemia (AML) in Italy
AOU San Giovanni di Dio Ruggi d'Aragona - Scuola Medica Salernitana /ID# 274319
Salerno, 84131
1 trial
- NCT06965374Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease
  Contact: Caterina Golotta
Ospedali riuniti San Giovanni di Dio e Ruggi d'Aragona
Salerno
1 trial
- NCT04999423LVIS™ Evo™ and HydroCoil® Embolic System for Intracranial Aneurysm Treatment
UOC di Ematologia - AOU San Giovanni di Dio e Ruggi D'Aragona
Salerno
1 trial
- NCT03367299Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic Leukemia
AOU San Giovanni Di Dio E Ruggi d'Aragona - Cardiologia - Torre Cardiologica
Salerno, Campania 84131
AOU San Giovanni di Dio e Ruggi D'Aragona, Università degli Studi di Salerno
Salerno, 84131

Conditions

Diseases this institution publishes on or runs trials for.

Myasthenia gravis8 works · 0 trials
Fabry disease5 works · 0 trials

Institution data: ROR 04etf9p48 (CC0-1.0)Updated 10 Nov 2026

Report an error